UCB SA (UCB-BT)

QUOTE AND NEWS
SeekingAlpha  Aug 8  Comment 
This week’s patent expirations are related to UCB’s (OTCPK:UCBJF) Vimpat, a seizure medication, and Genentech’s [now owned by Roche (OTCQX:RHHBY)] Nutropin Depot. Vimpat Vimpat launched in 2009 as an...
FiercePharma  Aug 6  Comment 
Shedding noncore assets is the trend du jour in Big Pharma, and now another company may be jumping on the bandwagon. Belgium's UCB is reportedly looking into a sale of Kremers Urban Pharmaceuticals, its Princeton, NJ-based generics unit.
Reuters  Aug 5  Comment 
Belgian pharmaceutical company UCB is exploring a sale of its Kremers Urban Pharmaceuticals Inc division, a U.S. specialty generics business that could fetch as much as $2...
SeekingAlpha  Jul 30  Comment 
UCB S.A. (OTCPK:UCBJF) Q2 2014 Results Earnings Conference Call July 30, 2014, 08:00 AM ET Executives Roch Doliveux - CEO Jean-Christophe Tellier - CEO-Elect Detlef Thielgen - EVP and CFO Analysts Richard Park - Deutsche...
FierceBiotech  Jul 23  Comment 
A new epilepsy treatment from Belgian drugmaker UCB helped reduce the rate of seizures in a Phase III trial, the company said, setting the stage for an FDA application and a shot at widening its footprint in the field.
Cloud Computing  Jul 7  Comment 
Infotrieve, Inc. (www.infotrieve.com), the leader in global-enterprise SaaS software and business services for scientific, technical and medical (“STM”) published content access and management, today announced that it has...
MedPage Today  Jun 19  Comment 
PARIS (MedPage Today) -- The benefits of treatment with certolizumab pegol (Cimzia) among patients with axial spondyloarthritis have persisted for 2 years, both for those with and without radiographic evidence of sacroiliitis, researchers reported...
newratings.com  May 21  Comment 
WILEX AG: WILEX returns rights from collaboration in oncology to UCB and UCB waives repayment of the shareholder loan WILEX AG / Key word(s): Agreement 21.05.2014 12:48 Dissemination of an Ad hoc announcement according to § 15 WpHG,...
Cloud Computing  May 7  Comment 
Catavolt, Inc., today announced the publication of a case study outlining UCB, Inc.'s success rapidly implementing Catavolt to solve a complex and challenging mobile workflow issue. The case study, entitled "UCB Improves Collaboration and...
FierceBiotech  May 1  Comment 
In this week's EuroBiotech Report, British trade unions and politicians are calling for guarantees that Pfizer won't perform its now-traditional post-takeover cuts in the event it succeeds in its pursuit of AstraZeneca, Ireland is worried that its...





You may also be interested in articles related to UCB SA (UCB-BT):
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki